The balance between concurrent activation of ERs and PPARs determines daidzein-induced osteogenesis and adipogenesis
about
Isoflavones are safe compounds for therapeutical applications - evaluation of in vitro data.Identification of upregulators of BMP2 expression via high-throughput screening of a synthetic and natural compound library.Neonatal administration of isoflavones attenuates deterioration of bone tissue in female but not male mice.Neuromodulation by soy diets or equol: anti-depressive & anti-obesity-like influences, age- & hormone-dependent effectsEvaluation of Osteogenesis and Angiogenesis of Icariin in Local Controlled Release and Systemic Delivery for Calvarial Defect in Ovariectomized Rats.Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.Osteoblast response to puerarin-loaded porous titanium surfaces: an in vitro study.Fine-Tuning Reception in the Bone: PPARgamma and Company.Reduction of body weight, liver steatosis and expression of stearoyl-CoA desaturase 1 by the isoflavone daidzein in diet-induced obesity.Potential health-modulating effects of isoflavones and metabolites via activation of PPAR and AhR.The Dietary Isoflavone Daidzein Reduces Expression of Pro-Inflammatory Genes through PPARα/γ and JNK Pathways in Adipocyte and Macrophage Co-Cultures.Identification of the Flavonoid Luteolin as a Repressor of the Transcription Factor Hepatocyte Nuclear Factor 4αAssociation of 17-β Estradiol with Adipose-Derived Stem Cells: New Strategy to Produce Functional Myogenic Differentiated Cells with a Nano-Scaffold for Tissue Engineering.Soy Isoflavones and Osteoporotic Bone Loss: A Review with an Emphasis on Modulation of Bone Remodeling.Effects of soy protein and isoflavones on insulin resistance and adiponectin in male monkeys.Differential regulation of senescence and in vitro differentiation by 17β-estradiol between mesenchymal stem cells derived from male and female mini-pigsPhyto-oestrogens and bone health.Puerarin promotes osteogenesis and inhibits adipogenesis in vitroThe effects of soy isoflavones on obesity.Flavonoids as dietary regulators of nuclear receptor activityControl of body weight versus tumorigenesis by concerted action of leptin and estrogen.A CCAAT/enhancer binding protein beta isoform, liver-enriched inhibitory protein, regulates commitment of osteoblasts and adipocytesEffects of daidzein on alveolar bone loss and internal microstructures of bone in a rat model of experimental periodontitis: a study using micro-computed tomography.Daidzein regulates proinflammatory adipokines thereby improving obesity-related inflammation through PPARγ.Regulation of soy isoflavones on weight gain and fat percentage: evaluation in a Chinese Guangxi minipig model.In vitro and in vivo effects of puerarin on promotion of osteoblast bone formation.Comparative effects of 17beta-estradiol and phytoestrogens in the regulation of endometrial functions in the rodent uterus.Anti-obesity molecular mechanism of soy isoflavones: weaving the way to new therapeutic routes.Equol, a Clinically Important Metabolite, Inhibits the Development and Pathogenicity of Magnaporthe oryzae, the Causal Agent of Rice Blast Disease.Effects of different doses of ferutinin on bone formation/resorption in ovariectomized rats.Osteoblast-targeted overexpression of PPARγ inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice.Influence of lifelong soy isoflavones consumption on bone mass in the rat.Pure flavonoid epicatechin and whole genome gene expression profiles in circulating immune cells in adults with elevated blood pressure: A randomised double-blind, placebo-controlled, crossover trial.Vinexin family (SORBS) proteins regulate mechanotransduction in mesenchymal stem cells
P2860
Q33480555-5A8D4762-B7B6-4760-9384-0B449F2E1002Q33505927-268CEB48-1C30-423C-A381-38B7E8E41902Q33531992-D53BEFD5-EDD4-47F4-B649-3CE6EF55DA0AQ33848586-7421C8C0-95A2-41C8-854F-F02E711F1A24Q33894857-CD08999F-989C-4418-A6AC-082D2D641A2FQ34063149-3D7C3F71-B6C7-4A45-8F22-300931E62692Q34177999-C29B5082-6024-4CDB-8FD5-25249BE91815Q35606046-0DA6F081-220F-4A7E-84BB-19B77E4A26FAQ35636132-85CFABD1-2FEE-4D66-99C6-EB7BD23CC2A7Q35670922-04113114-3125-4770-A656-6DABCB832EBDQ35931431-9DA6D04B-E1A7-4968-9714-6C6E83276F49Q36092936-8C791B4B-50BE-426E-8704-4AEAD2CA8571Q36175113-469DD1B4-7F15-4955-8658-E63FF496C8C8Q36475945-10A49A60-E4BC-4650-9BE6-4F77D3D225A7Q36943591-5B541555-760E-429F-BBF3-082AD0EFC4CBQ37039480-2AF09846-A3AB-4AA0-B6D2-9FD01965CE75Q37138656-2B39A8C0-3DC9-4559-85E5-089D67A5D7C7Q37152922-0890DE3E-7B2B-4B79-89D0-067AC2B407F2Q37183929-56727D04-5216-47BF-81FF-BF94D9854DBFQ37193003-29213C25-40EB-4411-A47D-40C7F7274FB6Q38154190-AFDB91D8-01F9-49E0-874C-A55345EF31C2Q40457879-8900BD50-9457-47BE-A389-5A531FAF328DQ40731731-3DB3A646-6E9E-4EB2-BE3E-438724D677C5Q42809120-93B1F33A-9D50-4F91-A572-E939B6FCDF31Q44752896-5D43EB99-85F1-4441-82AC-02BE66665A81Q46291343-21768413-8FEF-442C-BADF-B62A1F64418EQ46736146-B362F858-2042-4557-9687-54207DF49482Q47636158-305157AD-B779-4BC5-860B-920BC03BADEEQ50075656-C0F0E7D8-4FB8-45ED-88F5-D1CA065B77F7Q51323148-ADB0D6CE-6C52-4871-8B7C-C5F3A0999D69Q51500318-78F88AB1-0984-48A1-B663-0FA8559470EAQ51717819-BA891A70-2121-4F82-9DB9-2D2C5D203C71Q52577972-3AE77FBB-A473-4FE0-AC87-6706D65E7B89Q58449670-026D1720-5B41-4433-B19C-28814281F1DB
P2860
The balance between concurrent activation of ERs and PPARs determines daidzein-induced osteogenesis and adipogenesis
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The balance between concurrent ...... osteogenesis and adipogenesis
@ast
The balance between concurrent ...... osteogenesis and adipogenesis
@en
The balance between concurrent ...... osteogenesis and adipogenesis
@nl
type
label
The balance between concurrent ...... osteogenesis and adipogenesis
@ast
The balance between concurrent ...... osteogenesis and adipogenesis
@en
The balance between concurrent ...... osteogenesis and adipogenesis
@nl
prefLabel
The balance between concurrent ...... osteogenesis and adipogenesis
@ast
The balance between concurrent ...... osteogenesis and adipogenesis
@en
The balance between concurrent ...... osteogenesis and adipogenesis
@nl
P2860
P3181
P356
P1476
The balance between concurrent ...... osteogenesis and adipogenesis
@en
P2093
Clemens W G M Löwik
ZhiChao Dang
P2860
P304
P3181
P356
10.1359/JBMR.040120
P407
P577
2004-05-01T00:00:00Z